Kimberly Gibson-Cordes
Family · Hannibal, MONPI 1467854042
Payments from drug & device makers
What this record shows
Intuitive Surgical accounts for 64.3% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2022 at $9,212 and has fallen 90.9% since, to $836 in 2025. Among family clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 284 payments — averaging $45.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Amgen$819
- AbbVie$805
- Novo Nordisk$526
- Lilly USA, LLC$480
- Otsuka America Pharmaceutical, Inc.$265
- plus $2K from 36 others
What the payments were for
- Speaking & faculty fees$7,55059%
- Food & beverage$5,35541%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 5 | $8,300 |
| Amgen | 49 | $819 |
| AbbVie | 57 | $805 |
| Novo Nordisk | 34 | $526 |
| Lilly USA, LLC | 30 | $480 |
| Otsuka America Pharmaceutical, Inc. | 14 | $265 |
| AstraZeneca | 15 | $236 |
| GSK | 8 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $113 |
| Abbott | 5 | $106 |
| Pfizer | 6 | $103 |
| Verona Pharma, Inc. | 4 | $76 |
| Bayer | 4 | $76 |
| Merck | 4 | $70 |
| Boehringer Ingelheim | 3 | $50 |
| Astellas Pharma US Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $41 |
| Daiichi Sankyo Inc. | 2 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $39 |
| Lundbeck LLC | 2 | $38 |
| Sanofi | 1 | $38 |
| Nestle Healthcare Nutrition Inc. | 2 | $37 |
| Resmed Corp | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $24 |
| Globus Medical | 1 | $24 |
| Novartis | 1 | $23 |
| Nevro Corp. | 1 | $23 |
| Medtronic | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Viatris Specialty LLC | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Grifols USA, LLC | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,300
How this compares
$12,905 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $53,765 |
| TrulicityDulaglutide | 20 | $19,924 |
| EliquisApixaban | 14 | $15,544 |
| JardianceEmpagliflozin | 23 | $15,062 |
| MyrbetriqMirabegron | 25 | $9,679 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $7,169 |
| Tiagabine Hcl | 15 | $2,614 |
| Celecoxib | 36 | $1,108 |
| Omeprazole | 112 | $1,083 |
| Gabapentin | 46 | $987 |
| Atorvastatin Calcium | 111 | $774 |
| Bupropion XlBupropion Hcl | 30 | $688 |
| Ventolin HfaAlbuterol Sulfate | 11 | $647 |
| Memantine Hcl | 13 | $573 |
| Pantoprazole Sodium | 90 | $562 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $526 | $53,76540 claims |
| Lilly USA, LLCTrulicity | $480 | $19,92420 claims |
| PfizerEliquis | $103 | $15,54414 claims |
| Boehringer IngelheimJardiance | $50 | $15,06223 claims |
| Astellas Pharma US IncMyrbetriq | $42 | $9,67925 claims |
| GSKBreo Ellipta | $127 | $7,16918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Hannibal
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
- Jennifer GriggColumbia$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.